Envafolimab plus chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study

被引：0
|
作者：
Zhao, Jinbo [1 ]
Yan, Xiaolong [1 ]
Bai, Yuquan [1 ]
Duan, Hongtao [1 ]
Jiang, Tao [1 ]
机构：
[1] Air Force Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14633
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Neoadjuvant toripalimab plus chemotherapy in patients with potentially resectable non-small cell lung cancer: A prospective, single-arm, phase II trial (Renaissance Study)
    Yan, S.
    Chen, J.
    Wang, J.
    Lv, C.
    Bi, J.
    Yang, X.
    Li, S.
    Wang, Y.
    Li, X.
    Yang, Y.
    Wu, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
  • [43] Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study
    Zhang, Yong
    Che, Shaomin
    Chen, Nanzheng
    Li, Xinju
    Fu, Junke
    Yu, Chenao
    Wang, Tianren
    Liang, Runjia
    Xu, Haozhen
    Wu, Qifei
    Jia, Zhuoqi
    Zhu, Cailin
    Gong, Tuotuo
    Li, Haijun
    Zhang, Boxiang
    Hu, Yunyun
    Liu, Yaqi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Tislelizumab (TIS) plus chemotherapy (Chemo)/ chemoradiotherapy (CRT) as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (R-ESCC)
    Chen, L.
    Liao, Y.
    Jiang, T.
    Kang, M.
    Mei, X.
    Tan, L.
    Liu, J.
    Zhang, Z.
    Yu, W.
    Li, L.
    Jiang, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S1529 - S1529
  • [45] Neoadjuvant chemoradiotherapy (nCRT) combined with sequential tislelizumab for resectable esophageal squamous cell carcinoma (ESCC): Preliminary results of a single-arm, open-label phase Ib trial (CRIS)
    Jiang, Youhua
    Qiu, Guoqin
    Li, Jianqiang
    Wang, Jiangfeng
    Wang, Changchun
    Wu, Jie
    Cheng, Lei
    Zheng, Yuanda
    Ruan, Rongwei
    Song, Ge
    Ye, Xuemei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Neoadjuvant camrelizumab plus docetaxel and carboplatin in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective study
    Wang, R.
    Zhang, G.
    Zhu, Q.
    Ma, T.
    Weng, C.
    Zhang, D.
    Zeng, H.
    Wang, T.
    Gao, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1113 - S1113
  • [47] Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma
    Okamura, A.
    Watanabe, M.
    Mine, S.
    Kurogochi, T.
    Yamashita, K.
    Hayami, M.
    Imamura, Y.
    Ogura, M.
    Ichimura, T.
    Takahari, D.
    Chin, K.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 8
  • [48] A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer
    Duan, Hongtao
    Wang, Zhaoyang
    Cao, Lili
    Zhu, Yifang
    Tong, Liping
    Yan, Xiaolong
    THORACIC CANCER, 2024, 15 (19) : 1471 - 1476
  • [49] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Maohui Chen
    Yizhou Huang
    Shuliang Zhang
    Taidui Zeng
    Guanglei Huang
    Chun Chen
    Bin Zheng
    Trials, 24 (1)
  • [50] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Chen, Maohui
    Huang, Yizhou
    Zhang, Shuliang
    Zeng, Taidui
    Huang, Guanglei
    Chen, Chun
    Zheng, Bin
    TRIALS, 2023, 24 (01)
12345